Watch this on YouTube.
Concerns About AREDS 2
AREDS 2 has been widely recognized as the gold standard for supporting eye health, particularly for those at risk of age-related macular degeneration (AMD). However, some experts have raised concerns about the nutrient levels in the PreserVision® AREDS 2 Formula, particularly the high amounts of zinc, vitamin E, and vitamin C.
Zinc
One of the biggest concerns is zinc. The AREDS 2 formula contains 80 mg per day—double the tolerable upper limit of 40 mg recommended by many health organizations. While zinc is essential for eye health, high doses have been linked to urinary issues, with some studies suggesting an increased risk of hospitalization for these problems. Even more concerning, long-term zinc supplementation above 75 mg daily has been associated with nearly doubling the risk of aggressive prostate neoplasms.
Vitamin E
The formula also includes 400 IU of vitamin E per day, but research indicates that such high doses may increase the risk of hemorrhagic stroke. Additionally, findings from the SELECT trial suggest a slight increase in prostate neoplasm risk among men who took vitamin E supplements for seven years—though the effect was relatively minor.
Vitamin C
Vitamin C is another ingredient under scrutiny. The AREDS 2 formula provides 500 mg daily, which sounds beneficial, but some research suggests that long-term high doses might have a pro-oxidant effect on the eye’s lens, potentially increasing the risk of cataracts. In fact, studies on older adults have linked vitamin C supplementation—even at just 500 mg per day—to a higher likelihood of developing cataracts.
The Evolution of AREDS 2
The development of AREDS 2 is a testament to scientific progress in the fight against AMD, a leading cause of vision loss in older adults.
The journey began in the 1990s when the National Eye Institute launched the first Age-Related Eye Disease Study (AREDS). At the time, there were no effective treatments for AMD, putting millions at risk of severe vision loss. Researchers aimed to determine whether specific vitamins and antioxidants could slow the disease’s progression.
By 2001, the study’s results were in, and they were promising. A specific blend of vitamin C (500 mg), vitamin E (400 IU), beta-carotene (15 mg), zinc (80 mg), and copper (2 mg) was found to reduce the risk of advanced AMD by about 25%. These nutrients were chosen for their ability to combat oxidative stress, a key factor in AMD development.
As science advanced, so did the need to refine this formula, leading to the launch of the AREDS 2 study in 2006. Researchers sought to improve upon the original formula by addressing several key concerns.
First, beta-carotene, while effective, was found to increase lung neoplasm risk in smokers. Second, emerging research suggested that omega-3 fatty acids and the carotenoids lutein and zeaxanthin could provide additional eye health benefits. Third, some participants in the original study experienced digestive issues from high zinc levels.
To tackle these issues, AREDS 2 researchers tested several modifications:
- Replacing beta-carotene with lutein (10 mg) and zeaxanthin (2 mg) to determine if they provided similar or superior protection.
- Adding omega-3 fatty acids (350 mg and 650 mg doses) to assess their potential benefits.
- Lowering zinc from 80 mg to 25 mg to see if a reduced dose remained effective while minimizing side effects.
Over five years, the study followed more than 4,000 participants to evaluate these changes.
By 2013, the findings were clear. Replacing beta-carotene with lutein and zeaxanthin was just as effective—if not better—without posing a risk to smokers. Reducing zinc from 80 mg to 25 mg had no impact on effectiveness but could help reduce side effects. However, omega-3 fatty acids, while beneficial for overall health, did not significantly improve AMD outcomes.
Today, the most widely available version of this formula is PreserVision® AREDS 2, which largely adheres to these recommendations. However, one major point of contention remains: the formula still contains 80 mg of zinc rather than the lower 25 mg tested in AREDS 2. While this higher dose reflects the original study’s findings, it continues to be a topic of debate among experts.
How To Improve AREDS 2
Can the AREDS 2 formula be improved? Before diving into that, it’s important to clarify one key point: the health concerns surrounding AREDS 2 nutrients aren’t definitive. Taking these supplements won’t automatically cause issues, but at high doses and over the long term, they may increase certain health risks. If you’re using AREDS 2 for age-related macular degeneration (AMD), chances are you’re taking it consistently for years. That’s why it’s worth considering not just how these nutrients support eye health, but also their impact on overall well-being.
With that in mind, let’s look at a more practical, balanced, and long-term alternative to the standard AREDS 2 formula.
Lutein and Zeaxanthin
Lutein and zeaxanthin are the most important ingredients in the formula. These carotenoids play a crucial role in protecting the eyes, and research suggests that supplementing with them alone may be the most effective long-term strategy. Instead of a full AREDS 2 supplement, a simple, generic lutein and zeaxanthin combo with doses similar to those in the formula is a more affordable and likely sufficient option for most people.
Optional Zinc
Zinc is another key component, but the high dose in AREDS 2—80 mg per day—may not be necessary. While older adults can benefit from some zinc, a more moderate intake of around 20 mg daily is likely enough. This lower dose still supports AMD management while also addressing common age-related zinc deficiencies, which can lead to other health concerns.
No Copper
One common concern is that high doses of zinc can interfere with copper absorption, potentially leading to a rare condition called zinc-induced copper deficiency. However, research shows that this usually only becomes an issue with extremely high zinc intakes—typically between 100 and 300 mg per day. Since a more reasonable daily intake of 20 mg of zinc is unlikely to cause problems, there’s usually no need to supplement with additional copper.
No Vitamins C and E
Vitamins C and E are powerful antioxidants that help protect cells from damage, but supplementing with high doses doesn’t seem to provide additional benefits for most people. In fact, some research suggests that excessive amounts of antioxidants could even be harmful. Unless you have a specific deficiency or medical need, extra vitamin C and E supplementation is probably unnecessary—especially in developed countries where deficiencies are rare.
Summary
For most people, a generic lutein and zeaxanthin supplement, combined with a small amount of zinc for older adults, offers a simpler and more balanced alternative to the full AREDS 2 formula. This approach still provides the core nutrients needed for eye health while avoiding potential long-term risks associated with excessive supplementation.
Overall rating

Rating AREDS 2 by effectiveness for eye health, I’m giving it a B. There is good evidence that the AREDS 2 formula can help with AMD as well as possibly cataracts in some populations.
Rating it by cost, I’m giving it a B. It can be replicated at a cheaper cost, however is decently priced for a combination supplement.
Rating it for safety, I’m giving it a C. Although most ingredients are unlikely to be of much cause for concern, the high dose of zinc may cause some people issues.
Overall rating, I’m giving a B. It’s a good option for those looking to help improve eye health and reduce the risk of AMD. However, there are better alternatives out there.
Top alternatives to AREDS 2
- AREDS 2 – 2 caps / day
- Lutein and zeaxanthin – 1 cap / day
- Zinc citrate – 1 cap / day
Learn more about
Citations
Abeywickrama HM, Uchiyama M, Sumiyoshi T, Okuda A, Koyama Y. The role of zinc on nutritional status, sarcopenia, and frailty in older adults: a scoping review. Nutr Rev. 2024 Jun 10;82(7):988-1011. doi: 10.1093/nutrit/nuad094. PMID: 37550266; PMCID: PMC11163457.
Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials. 1999 Dec;20(6):573-600. doi: 10.1016/s0197-2456(99)00031-8. PMID: 10588299; PMCID: PMC1473211.
Age-Related Eye Disease Study 2 (AREDS2) Research Group; Chew EY, SanGiovanni JP, Ferris FL, Wong WT, Agron E, Clemons TE, Sperduto R, Danis R, Chandra SR, Blodi BA, Domalpally A, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Friberg TR, Rosenfeld PJ, Toth CA, Bernstein P. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol. 2013 Jul;131(7):843-50. doi: 10.1001/jamaophthalmol.2013.4412. PMID: 23645227; PMCID: PMC6774801.
Broadhead GK, Agrón E, Peprah D, Keenan TDL, Lawler TP, Mares J, Chew EY; AREDS/AREDS2 Investigators. Association of Dietary Nitrate and a Mediterranean Diet With Age-Related Macular Degeneration Among US Adults: The Age-Related Eye Disease Study (AREDS) and AREDS2. JAMA Ophthalmol. 2023 Feb 1;141(2):130-139. doi: 10.1001/jamaophthalmol.2022.5404. PMID: 36547942; PMCID: PMC9936348.
Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990 Feb;51(2):225-7. doi: 10.1093/ajcn/51.2.225. PMID: 2407097.
Gupta N, Carmichael MF. Zinc-Induced Copper Deficiency as a Rare Cause of Neurological Deficit and Anemia. Cureus. 2023 Aug 21;15(8):e43856. doi: 10.7759/cureus.43856. PMID: 37736439; PMCID: PMC10510946.
Jenkins DJA, et al. Supplemental Vitamins and Minerals for CVD Prevention and Treatment. J Am Coll Cardiol. 2018 Jun 5;71(22):2570-2584. doi: 10.1016/j.jacc.2018.04.020. PMID: 29852980.
Johnson AR, Munoz A, Gottlieb JL, Jarrard DF. High dose zinc increases hospital admissions due to genitourinary complications. J Urol. 2007 Feb;177(2):639-43. doi: 10.1016/j.juro.2006.09.047. PMID: 17222649.
Kemnic TR, Coleman M. Vitamin E Deficiency. 2023 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30085593.
Li S, Fasipe B, Laher I. Potential harms of supplementation with high doses of antioxidants in athletes. J Exerc Sci Fit. 2022 Oct;20(4):269-275. doi: 10.1016/j.jesf.2022.06.001. Epub 2022 Jun 11. PMID: 35812825; PMCID: PMC9241084.
Lippman SM, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009 Jan 7;301(1):39-51. doi: 10.1001/jama.2008.864. Epub 2008 Dec 9. PMID: 19066370; PMCID: PMC3682779.
NIH. Zinc. https://ods.od.nih.gov/factsheets/Zinc-Consumer/ Accessed Mar 11, 2025
Prasad AS, Fitzgerald JT, Hess JW, Kaplan J, Pelen F, Dardenne M. Zinc deficiency in elderly patients. Nutrition. 1993 May-Jun;9(3):218-24. PMID: 8353362.
Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. Vitamin C supplements and the risk of age-related cataract: a population-based prospective cohort study in women. Am J Clin Nutr. 2010 Feb;91(2):487-93. doi: 10.3945/ajcn.2009.28528. Epub 2009 Nov 18. PMID: 19923367.
Schürks M, Glynn RJ, Rist PM, Tzourio C, Kurth T. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010 Nov 4;341:c5702. doi: 10.1136/bmj.c5702. PMID: 21051774; PMCID: PMC2974412.
Zheng Selin J, Rautiainen S, Lindblad BE, Morgenstern R, Wolk A. High-dose supplements of vitamins C and E, low-dose multivitamins, and the risk of age-related cataract: a population-based prospective cohort study of men. Am J Epidemiol. 2013 Mar 15;177(6):548-55. doi: 10.1093/aje/kws279. Epub 2013 Feb 17. PMID: 23420353.
Zhang Y, Song M, Mucci LA, Giovannucci EL. Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study. Eur J Epidemiol. 2022 Dec;37(12):1251-1260. doi: 10.1007/s10654-022-00922-0. Epub 2022 Nov 3. PMID: 36326979; PMCID: PMC9630799.
Zhang Y, Yang J, Na X, Zhao A. Association between β-carotene supplementation and risk of cancer: a meta-analysis of randomized controlled trials. Nutr Rev. 2023 Aug 10;81(9):1118-1130. doi: 10.1093/nutrit/nuac110. PMID: 36715090.
See also
- Doctor Reviews: Liquid I.V.Liquid I.V. contains more sugar and less salt than the WHO oral rehydration solution, making it unsuitable for treating medical dehydration.
- Why Nail Fungus Lights DON’T WorkWhile laser light therapy can be an effective medical treatment for nail fungus, the over-the-counter lights aren’t the same.
- Doctor Reviews: Prime BiomePrime Biome is a mild probiotic that offers limited benefits for gut health and is unlikely to have any effect on skin health.
- The Truth About AREDS 2AREDS 2 is well-supported for eye health, including AMD, but some nutrients, like zinc, may be higher than needed.
- Doctor Reviews: Lipo GummiesLipo Gummies are just another type of apple cider vinegar (ACV) gummy, which dosen’t contain enough ACV to be useful.